International Biotechnology Trust PLC Regeneron Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 8,847 shares of REGN stock, worth $6.22 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares

8,847

Previous 27,000 67.23%

Holding current value

$6.22 Million

Previous $19.4 Million 62.47%

% of portfolio

2.47%

Previous 6.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $12.6 Million - $15.3 Million	-18,153 Reduced 67.23%	8,847 $7.28 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $11.1 Million - $13.1 Million	15,800 Added 141.07%	27,000 $19.4 Million
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $1.61 Million - $2.04 Million	-2,810 Reduced 20.06%	11,200 $7.72 Million
Q2 2022 Aug 16, 2022	BUY	$548.35 - $738.84 $1.05 Million - $1.41 Million	1,910 Added 15.79%	14,010 $23.7 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $2.39 Million - $2.95 Million	4,400 Added 57.14%	12,100 $7.64 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $16.9 Million - $20.1 Million	-29,500 Reduced 79.3%	7,700 $4.66 Million
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $3.12 Million - $3.69 Million	-6,600 Reduced 15.07%	37,200 $20.8 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $14.4 Million - $17.7 Million	32,300 Added 280.87%	43,800 $20.7 Million
Q2 2020 Jul 14, 2020	BUY	$493.32 - $643.92 $5.67 Million - $7.41 Million	11,500 New	11,500 $7.02 Million
Q1 2020 May 18, 2020	SELL	$336.18 - $494.43 $9.69 Million - $14.3 Million	-28,830 Closed	0 $0
Q4 2019 May 18, 2020	SELL	$274.13 - $376.51 $3.02 Million - $4.14 Million	-11,000 Reduced 27.62%	28,830 $10.8 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $4.51 Million - $5.25 Million	16,500 Added 70.72%	39,830 $11.1 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $2.49 Million - $3.44 Million	-8,300 Reduced 26.24%	23,330 $7.3 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $111,624 - $131,871	300 Added 0.96%	31,630 $13 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $94.3 Million - $110 Million	-268,670 Reduced 89.56%	31,330 $9.71 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $94.3 Million - $110 Million	268,670 Added 857.55%	300,000 $3.86 Million
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $1.34 Million - $1.62 Million	-4,700 Reduced 13.04%	31,330 $10.8 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.52 Million - $1.89 Million	-4,800 Reduced 11.76%	36,030 $12.4 Million
Q3 2017 Mar 02, 2018	SELL	$431.38 - $504.0 $3.15 Million - $3.68 Million	-7,300 Reduced 15.17%	40,830 $18.3 Million
Q2 2017 Mar 02, 2018	BUY	N/A	3,000 Added 6.65%	48,130 $23.6 Million
Q1 2017 Mar 02, 2018	BUY	N/A	12,700 Added 39.16%	45,130 $17.5 Million
Q4 2016 Mar 02, 2018	BUY	N/A	32,430	32,430 $11.9 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Regeneron Pharmaceuticals, Inc. Transaction History